Media & news

Nobel Biocare appoints new Chief Financial Officer

Nobel Biocare announced today that effective February 1, 2015, Mr. Tullio Di Dio will be appointed Chief Financial Officer of Nobel Biocare succeeding Mr. Oliver Walker as he has decided to leave the company to pursue his career interests outside Nobel Biocare.

Mr. Di Dio joins Nobel Biocare with 23 years of finance experience including assignments at United Technologies, Roche and during the past 12 years with Danaher. Most recently, Mr. Di Dio served as Vice President, Finance for Beckman Coulter EMEA. He played an important role in integrating Beckman Coulter into Danaher.  

Richard Laube, CEO of Nobel Biocare: “I wish to welcome Tullio Di Dio who will provide valuable experience as Nobel Biocare integrates into Danaher. At the same time, I wish Oliver Walker much success in his new endeavors and would like to thank him for his efforts and contributions in helping to turn Nobel Biocare around and make it a more predictable and performing business during his two and a half years of service. Our finance team has become a significantly more capable and effective organization with his leadership.”

Contact information:

Süha Demokan

Investor & Corporate Relations

Tel: +41 43 211 42 30, +41 79 430 81 46

suha.demokan@nobelbiocare.com

Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company’s portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive®, Brånemark System® and NobelReplace®), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), diagnostics, treatment planning and guided surgery solutions (NobelClinician® and NobelGuide®) and biomaterials (creos™). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland. Production takes place at six sites located in the United States, Sweden, Japan and Israel. Products and services are available in over 80 countries through subsidiaries and distributors.